These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9050775)

  • 1. The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity.
    Vohl MC; Lamarche B; Bergeron J; Moorjani S; Prud'homme D; Nadeau A; Tremblay A; Lupien PJ; Bouchard C; Després JP
    Atherosclerosis; 1997 Feb; 128(2):183-90. PubMed ID: 9050775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men.
    St-Pierre J; Lemieux I; Miller-Felix I; Prud'homme D; Bergeron J; Gaudet D; Nadeau A; Despres JP; Vohl MC
    Atherosclerosis; 2002 Feb; 160(2):317-24. PubMed ID: 11849654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome.
    Vohl MC; Lamarche B; Pascot A; Leroux G; Prud'homme D; Bouchard C; Nadeau A; Després JP
    Int J Obes Relat Metab Disord; 1999 Sep; 23(9):918-25. PubMed ID: 10490796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.
    Berthier MT; Houde A; Bergeron J; Prud'homme D; Després JP; Vohl MC
    J Hum Genet; 2003; 48(7):367-73. PubMed ID: 12851844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity.
    Vohl MC; Lamarche B; Moorjani S; Prud'homme D; Nadeau A; Bouchard C; Lupien PJ; Després JP
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):714-20. PubMed ID: 7749885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.
    St-Pierre J; Miller-Felix I; Paradis ME; Bergeron J; Lamarche B; Després JP; Gaudet D; Vohl MC
    Mol Genet Metab; 2003 Jan; 78(1):31-6. PubMed ID: 12559845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men.
    Vohl MC; Tchernof A; Dionne FT; Moorjani S; Prud'homme D; Bouchard C; Nadeau A; Lupien PJ; Després JP
    Diabetes; 1996 Oct; 45(10):1405-11. PubMed ID: 8826978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome.
    Couillard C; Lamarche B; Tchernof A; Prud'homme D; Tremblay A; Bouchard C; Moorjani S; Nadeau A; Lupien PJ; Després JP
    Metabolism; 1996 Jul; 45(7):882-8. PubMed ID: 8692026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?
    Lemieux S; Després JP; Moorjani S; Nadeau A; Thériault G; Prud'homme D; Tremblay A; Bouchard C; Lupien PJ
    Diabetologia; 1994 Aug; 37(8):757-64. PubMed ID: 7988777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
    Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP
    Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant.
    Tchernof A; Starling RD; Turner A; Shuldiner AR; Walston JD; Silver K; Poehlman ET
    Diabetes; 2000 Oct; 49(10):1709-13. PubMed ID: 11016455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels.
    Wang XL; Badenhop R; Humphrey KE; Wilcken DE
    Genet Epidemiol; 1996; 13(1):1-10. PubMed ID: 8647374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men.
    Couillard C; Vohl MC; Engert JC; Lemieux I; Houde A; Almeras N; Prud'homme D; Nadeau A; Despres JP; Bergeron J
    J Lipid Res; 2003 May; 44(5):986-93. PubMed ID: 12588953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial triglyceride response in visceral obesity in men.
    Couillard C; Bergeron N; Prud'homme D; Bergeron J; Tremblay A; Bouchard C; Mauriège P; Després JP
    Diabetes; 1998 Jun; 47(6):953-60. PubMed ID: 9604874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipoprotein lipids in relation to the MspI polymorphism of the apolipoprotein AII gene in Caucasian men. Lack of association with plasma triglyceride concentration.
    Rajput-Williams J; Eyre J; Nanjee MN; Crook D; Scott J; Miller NE
    Atherosclerosis; 1989 May; 77(1):31-6. PubMed ID: 2566309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of plasma apolipoprotein (apo) A-II levels associated with an apo A-II gene polymorphism in monozygotic twin pairs.
    Thorn JA; Stocks J; Reichl D; Alcolado JC; Chamberlain JC; Galton D
    Biochim Biophys Acta; 1993 Jan; 1180(3):299-303. PubMed ID: 7678506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes.
    Ma YQ; Thomas GN; Ng MC; Critchley JA; Cockram CS; Chan JC; Tomlinson B
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):442-9. PubMed ID: 14510906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
    Buring JE; O'Connor GT; Goldhaber SZ; Rosner B; Herbert PN; Blum CB; Breslow JL; Hennekens CH
    Circulation; 1992 Jan; 85(1):22-9. PubMed ID: 1728453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism.
    Moradi M; Mahmoudi M; Saedisomeolia A; Zahirihashemi R; Koohdani F
    Nutr J; 2017 May; 16(1):34. PubMed ID: 28545455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults.
    Ostlund RE; Staten M; Kohrt WM; Schultz J; Malley M
    N Engl J Med; 1990 Jan; 322(4):229-34. PubMed ID: 2403660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.